Supernus Pharmaceuticals' IPO

Supernus Pharmaceuticals raised a round of funding on May 01, 2012. Investors include Public.

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company is developi…

Articles about Supernus Pharmaceuticals' IPO: